Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1991; 66(02): 259-263DOI: 10.1055/s-0038-1646400 Scientific and Standardization Committee Communications Schattauer GmbH Stuttgart Inventory of Exogenous Platelet-Aggregating Agents Derived from Venoms Scott V Smith The Department of Pathology and Center for Thrombosis and Hemostasis CB #7525, University of North Carolina, Chapel Hill, NC, USA , K M Brinkhous The Department of Pathology and Center for Thrombosis and Hemostasis CB #7525, University of North Carolina, Chapel Hill, NC, USA › Author Affiliations Recommend Article Abstract PDF Download Buy Article PDF (1144 kb) References References 1 Teng C, Ko F. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb Haemostas 1988; 59: 304-9 2 Hill-Eubanks DC, Parker CG, Loller O. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 1989; 86: 6508-12 3 Schmaier AH, Claypool W, Colman RW. Crotalocytin: recognition and purification of a timber rattlesnake platelet aggregation protein. Blood 1980; 56: 1013-9 4 Schmaier AH, Colman RW. Crotalocytin: characterization of the timber rattlesnake platelet activating protein. Blood 1980; 56: 1020-8 5 Niewiarowski S, Kirby EP, Stocker K. Thrombocytin – a novel platelet activating enzyme from Bothrops atrox venom. Thromb Res 1977; 10: 863-9 6 Kirby EP, Niewiarowski S, Stocker K, Kettner C, Shaw E, Brudzynski TM. Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. Biochemistry 1979; 18: 3564-70 7 Niewiarowski S, Kirby EP, Brudzynski TM, Stocker K. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interactions with platelets and plasma-clotting factors. Biochemistry 1979; 18: 3570-7 8 Kubisz P, Arabi A, Seghier F, Cronberg S. Investigations on the effect of thrombocytin on platelets. Thromb Res 1984; 33: 225-7 9 Herzig RH, Ratnoff OD, Shainoff JR. Studies on a procoagulant fraction of southern copperhead snake venom: The preferential release of fibrinopeptide B. J Lab Clin Med 1970; 76: 451-65 10 Chen R, Chen Y. Isolation of an acidic phospholipase A2 from the venom of Agkistrodon acutus (five pace snake) and its effect on platelet aggregation. Toxicon 1989; 27: 675-82 11 Takagi J, Sekiya F, Kasahara K, Inada Y, Saito Y. Venom from southern copperhead snake (Agkistrodon contortrix contortrix). II. A unique phospholipase A2 that induces platelet aggregation. Toxicon 1988; 26: 199-206 12 Ouyang C, Huang T. Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function. Toxicon 1984; 22: 705-18 13 Heinrich D, Beckman S. Phospholipase A2-induced platelet aggregation, release and lysis. Thromb Haemostas 1979; 42: 246 (Abstr) 14 Teng C, Kuo Y, Lee L, Ouyang C. Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidoniç acid and lysophosphatidylcholine. Thromb Res 1986; 44: 875-86 15 Teng C, Chen Y, Ouyang C. Biphasic effect on platelet aggregation by phospholipase A purified from Vipera russelli snake venom. Biochim Biophys Acta 1984; 772: 393-402 16 Teng C, Chen Y, Ouyang C. Effect of Russell's Viper venom phospholipase A on blood coagulation and platelet aggregation. Semin Thromb Hemostas 1985; 11: 367-72 17 Ogilvi ML, Dockter ME, Wenz L, Gartner TK. Isolation and characterization of lactose-binding lectins from the venoms of the snakes Lachesis muta and Dendroaspis jamesonii. . J Biochem 1986; 100: 1425-31 18 Ogilvie ML, Byl JW, Gartner TK. Platelet aggregation is stimulated by lactose-inhibitable snake venom lectins. Thromb Haemostas 1989; 62: 704-7 19 Gartner TK, Stocker K, Williams DC. Thrombolectin: a lectin isolated from Bothrops atrox venom. FEBS Lett 1980; 117: 13-6 20 Gartner TK, Ogilvie ML. Isolation and characterization of three Ca2+-dependent β-galactosides – specific lectins from snake venoms. Biochem J 1984; 224: 301-7 21 Ouyang C, Yeh H, Huang T. Purification and characterization of a platelet aggregation inducer from Calloselasma rhodostoma (Malayan Pit Viper) snake venom. Toxicon 1986; 24: 633-43 22 Vargaftig BB, Prado-Franceschi J, Chignard M, Lefort J, Marlas G. Activation of guinea pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella. . Eur J Pharmacol 1980; 68: 451-64 23 Prado-Franceschi J, Tavares DQ, Hertel R, Lobo de Araújo A. Effects of convulxin, a toxin from rattlesnake venom, on platelets and leukocytes of anesthetized rabbits. Toxicon 1981; 19: 875-87 24 Prado-Franceschi J, Vital Brazil O. Convulxina, uma nova neurotoxina da peconha da Crotalus durissus terrificus. . Presented at the IX Congr Latino-Americano Cienc Fisiolog Brazil 1969; pp 91-2 25 Marlas G. Purification and preliminary structure of a potent platelet aggregating glycoprotein isolated from the venom of Crotalus durissus cascavella. . Toxicon 1982; 20: 289-90 26 Marlas G, Joseph D, Huet C. I. Isolation and electron microscope studies of a potent platelet-aggregating glycoprotein from the venom of Crotalus durissus cascavella. . Biochimie 1983; 65: 405-16 27 Marlas G, Joseph D, Huet C. II. Subunit structure of a potent platelet-aggregating glycoprotein from the venom of Crotalus durissus cascavella. . Biochimie 1983; 65: 619-28 28 Vargaftig BB, Joseph D, Wal F, Marlas G, Chignard M, Chevance LG. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitization with collagen. Eur J Pharmacol 1983; 92: 57-68 29 Vargaftig BB. Platelet activation by non-coagulant snake venom components. Toxicon 1982; 20: 279-87 30 Ouyang C, Huang T. A potent platelet aggregation inducer from Trimeresurus gramineus snake venom. Biochim Biophys Acta 1983; 761: 126-34 31 Chen JH, Wan H, Ruan C. Activation of human platelets induced by the aggregoserpentin of Trimeresurus mucrosquamatus venom (TMVA). In: Hemostasis and Animal Venoms.. Pirkle H, Maryland Jr FS. (Eds) Marcel Dekker, Inc, New York: 1988. pp 411-21 32 Ouyang C, Teng CM. The action mechanism of the purified platelet aggregation principle of Trimeresurus mucrosquamatus venom. Thromb Haemostas 1979; 41: 475-90 33 Teng CM, Liao KK, Wang JP, Lin HS, Ouyang C. Ultrastructural changes and release reaction of platelets induced by an aggregation inducer purified from Trimeresurus mucrosquamatus (Formosan Habu) snake venom. Toxicon 1981; 19: 121-30 34 Ouyang C, Wang JP, Teng CM. A potent platelet aggregation inducer purified from Trimeresurus mucrosquamatus snake venom. Biochim Biophys Acta 1980; 630: 246-53 35 Teng CM, Jy W, Ouyang C. Cardiotoxin from Naja naja atra snake venom: a potentiator of platelet aggregation.. Toxicon 1984; 22: 463-70 35a Teng C, Kuo Y, Lee L, Ouyang C. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom. Toxicon 1987; 25: 201-10 36 Dodds WJ, Pickering RJ. Purified cobra venom factor: effect on blood platelets. Proc Soc Exp Biol Med 1972; 140: 429-34 37 Dodds WJ, Pickering RJ. The effect of cobra venom factor on hemostasis in guinea pigs,. Blood 1972; 40: 400-11 38 Davey MG, Esnouf MP. The isolation of a component of the venom of Trimeresurus okinavensis that causes the aggregation pf blood platelets. Biochem J 1969; 111: 733-43 39 Davey MG, Lüscher EF. Actions of some coagulant snake venoms on blood platelets. Nature 1965; 207: 730-2 40 Read MS. Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514-8 41 Brinkhous KM, Read MS. Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor. Blood 1980; 55: 517-20 42 Brinkhous KM, Read MS, Reddick RL, Griggs TR. Pathophysiology of platelet aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay. Ann NY Acad Sci 1981; 370: 191-204 43 Brinkhous KM, Barnes DS, Potter JY, Read MS. Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin. Proc Natl Acad Sci USA 1981; 78: 3230-4 44 Howard MS, Salem HH, Thomas KB, Hau L, Perkin J, Coghlan M, Firkin BG. Variant von Willebrand's disease type B-revisited. Blood 1982; 60: 1420-8 45 Brown WH, Read MS, Barnes DS, Flynn TC, Sanders WE, Brinkhous KM. Response of von Willebrand disease pigs and dogs to venom coagglutinin. Fed Proc 1982; 41: 705 46 Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-6 47 Read MS, Potter JY, Brinkhous KM. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J Clin Lab Med 1983; 101: 74-82 48 Furlan M, Perret BA, Felix R, Beck EA. Quantitative und qualitative Beurteilung des Faktor VIII/von Willebrandsche Krankheit. Beziehung zwischen Molekülgröße, Botrocetin-Cofaktor und Latex-Antigen. Schweiz Med Wochenschr 1984; 114: 1391-3 49 Howard MA, Perkin J, Salem HH, Firkin BG. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane. Br Haematol 1984; 57: 25-35 50 Takahashi H, Nagayama R, Hattori A, Shibata A. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease. Am J Hematol 1985; 18: 179-89 50a Fricke WA, Brinkhous KM, Garris JB, Roberts HR. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody. Blood 1985; 66: 562-9 51 Fujimura Y, Holland LZ, Ruggeri ZM, Zimmerman TS. The von Willebrand factor domain-mediating botrocetin-induced binding to glycoprotein lb lies between Val449 and Lys728 . Blood 1985; 70: 985-8 52 Sanders WE, Read MS, Reddick RL, Garris JB, Brinkhous KM. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin: an animal model. Lab Invest 1988; 59: 443-52 53 Brinkhous KM, Smith SV, Read MS. Botrocetin and von Willebrand factor. In: Hemostasis and Animal Venoms. Pirkle H, Markland Jr FS. (eds) Marcel Dekker, Inc., New York: 1988. pp 377-98 54 Brinkhous KM, Read MS. Fixation of platelets and platelet agglutination/aggregation tests. In: Methods in Enzymology, Platelets: Receptors, Adhesion, Secretion. Part A, Vol. 169.. Hawiger J. (ed) Academic Press, San Diego, CA: 1989. pp 149-63 55 Read MS, Smith SV, Lamb MA, Brinkhous KM. Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Willebrand factor. Blood 1989; 74: 1031-5 55a Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317-26 56 Ouyang C, Ma Y, Jih H, Teng C. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim Biophys Acta 1985; 841: 1-7 57 Teng C, Ma Y, Ouyang C. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim Biophys Acta 1985; 841: 8-14 58 Marshall LR, Herrmann RP. Australian snake venoms and their in vitro effect on human platelets. Thromb Res 1989; 54: 269-75 59 Marshall LR, Herrmann RP. Plasma co-factors necessary for Enhydrina schistosa (Beaked sea snake) venom to induce platelet aggregation. Thromb Res 1986; 43: 229-35 60 Kurpiewski G, Forrester LJ, Barrett JT, Campbell BJ. Platelet aggregation and sphingomyelinase D activity of purified toxin from the venom of Loxosceles reclusa. . Biochim Biophys Acta 1980; 678: 467-76 61 Rees RS, Gates C, Timmons S, Des Prez RM, King Jr LE. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. . Toxicon 1981; 26: 1035-45 62 Brink S, Steytler JG. Effects of puff-adder venom on coagulation, fibrinolysis and platelet aggregation in the baboon. SA Med J 1974; 48: 1205-13 63 Phillips LL, Weiss HJ, Pessar L, Christy NP. Effects of puff adder venom on the coagulation mechanism. I. In vivo. Toxicon 1973; 11: 423-30 64 Phillips LL, Weiss HJ, Christy NP. Effects of puff adder venom on the coagulation mechanism. II. In vitro. Thromb Diath Haemorrh 1973; 30: 499-508 65 Warrell DA, Ormerod LD, McDavidsoň N. Bites by puff-adder (Bitis arietans) in Nigeria, and values of antivenom. Br Med J 1975; 4: 697-700 66 MacKay N, Ferguson JC, McNicol GP. Effects of the venom of the rhinoceros horned viper (Bitis nasicornis) on blood coagulation, platelet aggregation, and fibrinolysis. J Clin Pathol 1970; 23: 789-96 67 Soslau G, El-Asmar MF, Parker J. Cerastes cerastes (Egyptian Sand Viper) venom induced platelet aggregation as compared to other agonists. Biochem Biophys Res Commun 1988; 150: 909-16 68 Hardy DL, Jeter M, Corrigan Jr JJ. Envenomation by the northern blacktail rattlesnake (Crotalus molossus molossus): report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation. Toxicon 1988; 20: 487-93 69 Mitrakul C. Effects of green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: Studies in vivo and in vitro. Am J Clin Pathol 1973; 60: 654-62 70 Iddon D, Theakston RDG. Biological properties of the venom of the red-necked keel-back snake (Rhabdophis subminiatus). . Ann Trop Med Parasitol 1986; 80: 339-44 71 Brinkhous KM, Smith SV. Platelet-aggregating noncoagulant snake venom fractions: an overview. In: Hemostasis and Animal Venoms.. Pirkle H, Markland Jr FS. (eds) Marcel Dekker, Inc., New York: 1988. pp 363-76 72 Stocker KF, Meier J. Thrombin-like snake venom enzymes. In: Hemostasis and Animal Venoms.. Pirkle H, Markland Jr FS. (eds) Marcel Dekker, Inc., New York: 1988. pp 67-84 73 Kini RM, Evans HJ. A model to explain the pharmacological effects of snake venom phospholipases A2 . Toxicon 1989; 27: 613-35 74 Kornalik F. The influence of snake venoms on blood coagulation. Pharmac Ther 1985; 29: 353-405 75 Stocker K. Snake venom proteins affecting hemostasis and fibrinolysis. In: Medical Use of Snake Venom Proteins.. Stocker K. (ed) CRC Press, Boston, MA: 1990. pp 97-160 76 Stocker K. Application of snake venom proteins in the diagnosis of hemostatic disorders. In: Medical Use of Snake Venom Proteins. Stocker K. (ed) CRC Press, Boston, MA: 1990. pp 213-52
